Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Kala Pharmaceuticals Inc (KALA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2017 Equity Incentive...

KALA : 7.60 (-0.26%)
Research Report Identifies Dean Foods, Kala Pharmaceuticals, Buckeye Partners, Rockwell Medical, United Fire Group, and Clearwater Paper with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dean Foods Company (NYSE:DF),...

DF : 2.12 (+0.95%)
RMTI : 4.75 (unch)
UFCS : 42.58 (+0.64%)
KALA : 7.60 (-0.26%)
BPL : 33.15 (-0.45%)
CLW : 19.55 (+0.21%)
Kala Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 7.60 (-0.26%)
Implied Volatility Surging for Kala Pharmaceuticals (KALA) Stock Options

Kala Pharmaceuticals (KALA) needs investors to pay close attention to the stock based on moves in the options market lately.

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

--August 15, 2019 Prescription Drug User Fee Act (PDUFA) target action date for KPI-121 0.25% for the temporary relief of signs and symptoms of dry eye disease

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

KALA : 7.60 (-0.26%)
ACTO Emerges as a Leader in Life Sciences Commercialization; Closes Strong Calendar Year 2018 with 184% Revenue Growth and Doubled Customer Base

ACTO Technologies Inc. emerged as a leader in life sciences commercialization by closing a strong calendar year 2018 with 184% revenue growth and a doubled customer base. This past year, ACTO secured global,...

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2017 Equity Incentive...

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating...

JPM : 113.46 (-0.73%)
KALA : 7.60 (-0.26%)
Detailed Research: Economic Perspectives on American Airlines Group, Sandstorm Gold, Kala Pharmaceuticals, Adecoagro S.A, Novagold Resources, and Atossa Genetics -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of American Airlines Group Inc....

SAND : 5.47 (-0.91%)
KALA : 7.60 (-0.26%)
NG : 4.12 (-0.96%)
ATOS : 2.54 (-3.05%)
AAL : 34.37 (-0.03%)
AGRO : 6.87 (-0.29%)
Kala Pharmaceuticals Announces New Drug Application for KPI-121 0.25% for Dry Eye Disease Has Been Accepted for Review by the U.S. Food and Drug Administration

--- PDUFA target action date of August 15, 2019 -

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2017 Equity Incentive...

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals Reports First Quarter 2018 Financial Results

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle...

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch

--PDUFA Target Action Date for INVELTYS(TM) is August 24, 2018

KALA : 7.60 (-0.26%)
Kala Pharmaceuticals to Present at Upcoming Investor Conferences

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle...

KALA : 7.60 (-0.26%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.08
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar